Metaphase Medical Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 4 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 364.42%
- Profit Growth 272.52%
- Ebitda 422.74%
- Net Worth 807.82%
- Total Assets 36.53%
About Metaphase Medical Diagnostics
Metaphase Medical Diagnostics Private Limited (MMDPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 February 2020 (Five years 4 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Non-Profit Organizations Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Akshar Puli and Nanda Puli serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85320PN2020PTC189993
- Company No.
189993
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Feb 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Metaphase Medical Diagnostics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Akshar Puli  | Director | 20-Feb-2020 | Current |
| Nanda Puli | Director | 20-Feb-2020 | Current |
Financial Performance of Metaphase Medical Diagnostics.
Metaphase Medical Diagnostics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 364.42% increase. The company also saw a substantial improvement in profitability, with a 272.52% increase in profit. The company's net worth Soared by an impressive increase of 807.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Metaphase Medical Diagnostics?
In 2022, Metaphase Medical Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Innoveats Hospitality Private LimitedAkshar Puli is a mutual person
- Rebelhive Holdings Private Limited
Akshar Puli is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Metaphase Medical Diagnostics?
Unlock and access historical data on people associated with Metaphase Medical Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Metaphase Medical Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Metaphase Medical Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.